Sona Nanotech has signed a binding licensing agreement with in-vitro diagnostics developer Arlington Scientific to market the former’s quick saliva Covid-19 test. Under the deal, Sona will license the intellectual property for its rapid saliva Covid-19 test to Arlington. Arlington will seek an Emergency Use Authorization from the US Food and Drug Administration for use in the point-of-care as well as at-home setting. Arlington can produce and supply the test in the US on obtaining approval. The test has demonstrated a sensitivity and specificity of 93% and 100%, respectively.
Japan has plans to offer free Covid-19 tests to people showing no symptoms of SARS-CoV-2 infection. This move is anticipated to help protect the country against a potential surge of Covid-19 cases. To date, Covid-19 tests are offered free to individuals having virus-associated symptoms and those exposed to infection. Testing centres will be chosen by prefectural governments. Covid-19 has claimed over 18,000 lives in the country.
Go deeper with GlobalData
Several mayors from both sides of the US-Canada border have urged the Canadian federal government to scrap the Covid-19 test mandate for fully vaccinated travellers, CBC reported. Following 19 months of closure, the US has now reopened the land border for fully inoculated tourists. Border-town mayors noted that vaccinated people who enter Canada are required to furnish negative results from an expensive molecular test.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
